HDFC Life Insurance, one of the leading insurance companies in India, recently reported a strong performance for the quarter ended December 2024. The company’s net profit saw a significant increase of 14% to reach ₹415 crore compared to ₹365 crore in the same period last year. Despite this positive development, the total income for the quarter declined to ₹16,914 crore from ₹26,694 crore in the year-ago period.
Key highlights from the quarter include a 20% year-on-year growth in annual premium equivalent (APE) and a 14% increase in the value of new business (VNB). However, the VNB margin saw a decline of 140 basis points to 25.1%. Analysts attribute the challenges faced by the company, such as open architecture, lower tax exemptions, and a hike in surrender charges, to the drop in VNB margin.
Several brokerages have expressed optimism about the future prospects of HDFC Life Insurance. JM Financial maintained a buy rating on the stock with a target price of ₹900, highlighting the minor blip in growth during Q3 and expecting a 17% APE growth for Q4. Nuvama Institutional Equities raised their target price to ₹850, citing improved margins and successful pass-through of increased surrender values. Motilal Oswal reiterated a buy rating at a target price of ₹800, emphasizing the minimal impact of commission structure changes on VNB margins.
Other global brokerages like Investec, Jefferies, and HSBC have assigned buy ratings with varying target prices. Centrum Institutional Research sees a 31% upside potential at a target price of ₹780, driven by robust demand in tier-2/3 markets and steady market share in HDFC Bank channel. Yes Securities maintained an ‘add’ rating with a revised target price of ₹700, while Elara Capital recommended accumulating the stock at the same target price.
However, ICICI Securities downgraded the stock from ‘add’ to ‘buy’ with a target price of ₹700, citing potential regulatory risks ahead. Macquarie maintained a neutral stance with a target price of ₹570, emphasizing the muted VNB growth driven by lower APE growth.
In summary, HDFC Life Insurance’s strong performance in the quarter has garnered positive responses from brokerages, with many maintaining buy ratings and optimistic outlooks for the future. The stock closed nearly 8% higher on the NSE, reflecting investor confidence in the company’s growth trajectory.
